1.Wu Y L，Wang Q，Mao W M，et al. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stageⅡ-ⅢA（N1-N2）EGFR-mutant NSCLC（ADJUVANT/CTONG1104）：a randomised，open-label，phase 3 study.Lancet Oncology，2018，19（1）：139.

2.Zheng D，Ye T，Hu H，et al. Upfront surgery as first-line therapy in selected patients with stage ⅢA non-small cell lung cancer. J Thorac Cardiovasc Surg，2017，doi：10.1016/j.jtcvs.2017.10.075. ［Epub ahead of print］

3.Li R，Li X，Xue R，et al. Early metastasis detected in patients with multifocal pulmonary ground-glass opacities（GGOs）. Thorax，2018；73（3）：290-292.

4.Zhang L，Li M，Li Z，et al. Three-dimensional printing of navigational template in localization of pulmonary nodule：A pilot study. J Thorac Cardiovasc Surg，2017，154（6）：2113-2119.

5.Chen K，Chen W，Cai J，et al. Favorable prognosis and high discrepancy of genetic features in surgical patients with multiple primary lung cancers. J Thorac Cardiovasc Surg. 2018；155（1）：371-379.

6.Liang H，Liang W，Zhao L，et al. Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Cancer：A Meta-analysis. Annals of Surgery，2017.doi：10.1097/SLA.0000000000002346. ［Epub ahead of print］

7.Chen K，Wang X，Yang F，Li J，Jiang G，Liu J，Wang J，Propensity-matched Comparison of Video-assisted Thoracoscopic with Thoracotomy Lobectomy for Locally Advanced Non-Small Cell Lung Cancer，J Thorac Cardiovasc Surg，2017；153：967-976.

8.Wu Y L，Cheng Y，Zhou X，et al. Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer（ARCHER 1050）：a randomised，open-label，phase 3 trial. Lancet Oncol. 2017，18（11）：1454-1466.

9.Mok T S，Wu Y，Ahn M，et al. Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer［J］.N Engl J Med. 2017，376（7）：629-640.

10.Yang J J，Zhou C，Huang Y，et al. Icotinib versus whole-brain irradiation in patients with EGFR-mutant nonsmall-cell lung cancer and multiple brain metastases（BRAIN）：a multicentre，phase 3，open-label，parallel，randomised controlled trial［J］. Lancet Respir Med. 2017，5（9）：707-716.

11.Peters S，Camidge D R，Shaw A T，et al. Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer［J］. N Engl J Med. 2017，377（9）：829-838.

12.Nokihara H，Lu S，Mok T，et al. Randomized controlled trial of S-1 versus docetaxel in patients with non-smallcell lung cancer previously treated with platinum-based chemotherapy（East Asia S-1 Trial in Lung Cancer）.Ann Oncol. 2017，28（11）：2698-2706.

13.J. Liang，N. Bi，S. Wu，et al. Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage Ⅲ non-small cell lung cancer：a multicenter randomized phase Ⅲ trial. Ann Oncol. 2017，1；28（4）：777-783.

14.Xu J，Yang H，Fu X，et al. Prophylactic Cranial Irradiation for Patients with Surgically Resected Small Cell Lung Cancer. J Thorac Oncol. 2017，12（2）：347-353.

15.Deng X，Zheng Z，Lin B，et al. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases. BMC Cancer. 2017，17（1）：42.

16.Aupérin A，Le Péchoux C，Rolland E，et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol. 2010，28（13）：2181-2190.

17.Gregor A，Cull A，Stephens RJ，et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer：results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research（UKCCCR）and the European Organization for Research and Treatment of Cancer（EORTC）. Eur J Cancer 1997，33（11）：1752-1758.

18.Ohonoshi T，Ueoka H，Kawahara S，et al. Comparative study of prophylactic cranial irradiation in patients with small cell lung cancer achieving a complete response：a long-term follow-up result. Lung Cancer 10（1-2）：47-54.

19.Laplanche A，Monnet I，Santos-Miranda JA，et al. Controlled clinical trial of prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Lung Cancer 21（3）：193-201.

20.Arriagada R，Le Chevalier T，Riviere A，et al. Patterns of failure after prophylactic cranial irradiation in smallcell lung cancer：analysis of 505 randomized patients. Ann Oncol 13（5）：748-754.

21.Meert AP，Paesmans M，Berghmans T，et al. Prophylactic cranial irradiation in small cell lung cancer：a systematic review of the literature with meta-analysis. BMC Cancer 2001；1：5.

22.Socha J，Kepka L. Prophylactic cranial irradiation for small-cell lung cancer：how，when and for whom? Expert Rev Anticancer Ther 2012，12（4）：505-17. 23. Takei H，Kondo H，Miyaoka E，et al. Surgery for small cell lung cancer：a retrospective analysis of 243 patients from Japanese Lung Cancer Registry in 2004. J Thorac Oncol 9（8）：1140-1145.